Schrodinger Gross Margin 2019-2026 | SDGR
Current and historical gross margin for Schrodinger (SDGR) over the last 10 years. The current gross profit margin for Schrodinger as of June 30, 2026 is %.
| Schrodinger Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $0.26B | $0.15B | 56.76% |
| 2026-03-31 | $0.26B | $0.14B | 55.29% |
| 2025-12-31 | $0.26B | $0.14B | 55.47% |
| 2025-09-30 | $0.26B | $0.15B | 57.98% |
| 2025-06-30 | $0.24B | $0.14B | 58.40% |
| 2025-03-31 | $0.23B | $0.14B | 62.61% |
| 2024-12-31 | $0.21B | $0.13B | 63.77% |
| 2024-09-30 | $0.19B | $0.13B | 65.28% |
| 2024-06-30 | $0.20B | $0.13B | 65.67% |
| 2024-03-31 | $0.19B | $0.12B | 60.85% |
| 2023-12-31 | $0.22B | $0.14B | 65.44% |
| 2023-09-30 | $0.20B | $0.12B | 61.50% |
| 2023-06-30 | $0.19B | $0.12B | 59.79% |
| 2023-03-31 | $0.20B | $0.12B | 60.41% |
| 2022-12-31 | $0.18B | $0.10B | 55.80% |
| 2022-09-30 | $0.17B | $0.09B | 51.76% |
| 2022-06-30 | $0.16B | $0.08B | 50.31% |
| 2022-03-31 | $0.16B | $0.08B | 49.68% |
| 2021-12-31 | $0.14B | $0.07B | 47.10% |
| 2021-09-30 | $0.13B | $0.06B | 46.40% |
| 2021-06-30 | $0.12B | $0.06B | 51.24% |
| 2021-03-31 | $0.11B | $0.06B | 56.14% |
| 2020-12-31 | $0.11B | $0.06B | 59.26% |
| 2020-09-30 | $0.10B | $0.06B | 60.40% |
| 2020-06-30 | $0.10B | $0.06B | 60.00% |
| 2020-03-31 | $0.09B | $0.05B | 58.24% |
| 2019-12-31 | $0.09B | $0.05B | 58.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.532B | $0.256B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |